These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 15973860)
21. Use of the metabolic syndrome in pediatrics: a blessing and a curse. Battista M; Murray RD; Daniels SR Semin Pediatr Surg; 2009 Aug; 18(3):136-43. PubMed ID: 19573755 [TBL] [Abstract][Full Text] [Related]
22. The effects of pre-disease risk factors within metabolic syndrome on all-cause and cardiovascular disease mortality. Tsai SP; Wen CP; Chan HT; Chiang PH; Tsai MK; Cheng TY Diabetes Res Clin Pract; 2008 Oct; 82(1):148-56. PubMed ID: 18757109 [TBL] [Abstract][Full Text] [Related]
23. Cardiovascular risk factor prevalence among men in a large industry of northern India. Prabhakaran D; Shah P; Chaturvedi V; Ramakrishnan L; Manhapra A; Reddy KS Natl Med J India; 2005; 18(2):59-65. PubMed ID: 15981439 [TBL] [Abstract][Full Text] [Related]
24. Depressive symptoms and stressful life events predict metabolic syndrome among middle-aged women: a comparison of World Health Organization, Adult Treatment Panel III, and International Diabetes Foundation definitions. Räikkönen K; Matthews KA; Kuller LH Diabetes Care; 2007 Apr; 30(4):872-7. PubMed ID: 17392548 [TBL] [Abstract][Full Text] [Related]
25. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome. Liu J; Grundy SM; Wang W; Smith SC; Vega GL; Wu Z; Zeng Z; Wang W; Zhao D Am Heart J; 2007 Apr; 153(4):552-8. PubMed ID: 17383293 [TBL] [Abstract][Full Text] [Related]
26. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia. Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343 [TBL] [Abstract][Full Text] [Related]
27. Current understanding of multiple risk factors as the metabolic syndrome: distillation or deconstruction. Boden-Albala B Semin Neurol; 2006 Feb; 26(1):108-16. PubMed ID: 16479449 [TBL] [Abstract][Full Text] [Related]
28. Metabolic syndrome: screening, diagnosis, and management. Miller EL; Mitchell A J Midwifery Womens Health; 2006; 51(3):141-51. PubMed ID: 16647666 [TBL] [Abstract][Full Text] [Related]
33. The metabolic syndrome and cardiometabolic risk: scope of the problem and current standard of care. Lender D; Sysko SK Pharmacotherapy; 2006 May; 26(5 Pt 2):3S-12S. PubMed ID: 16637782 [TBL] [Abstract][Full Text] [Related]
35. The metabolic syndrome and cardiovascular disease. Bonora E Ann Med; 2006; 38(1):64-80. PubMed ID: 16448990 [TBL] [Abstract][Full Text] [Related]
36. Effect of heart rate on the risk of developing metabolic syndrome. Inoue T; Iseki K; Iseki C; Ohya Y; Kinjo K; Takishita S Hypertens Res; 2009 Sep; 32(9):801-6. PubMed ID: 19644506 [TBL] [Abstract][Full Text] [Related]
37. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Hanley AJ; Karter AJ; Williams K; Festa A; D'Agostino RB; Wagenknecht LE; Haffner SM Circulation; 2005 Dec; 112(24):3713-21. PubMed ID: 16344402 [TBL] [Abstract][Full Text] [Related]